Jun 05, 2025 11:10am EDT MAIA Biotechnology Announces New Responder in Non-Small Cell Lung Cancer Phase 2 Clinical Trial
Jun 05, 2025 8:04am EDT MAIA Biotechnology Announces Positive Efficacy Update for Phase 2 THIO-101 Clinical Trial in Non-Small Cell Lung Cancer
May 27, 2025 4:30pm EDT CORRECTING and REPLACING MAIA Biotechnology Announces Private Placement of Approximately $695,000
May 15, 2025 11:05am EDT MAIA Biotechnology Accepted for Poster Presentation at American Society of Clinical Oncology (ASCO) 2025 Annual Meeting
May 14, 2025 10:15am EDT MAIA Biotechnology Announces Director Participation in Recent Private Placement
Apr 01, 2025 8:30am EDT MAIA Biotechnology CEO Details Anticipated Clinical Milestones for Novel Cancer Immunotherapy in 2025 Letter to Shareholders
Mar 25, 2025 8:46am EDT MAIA Biotechnology Announces Poster Presentation at ESMO's European Lung Cancer Congress 2025
